# DIBBS #SPE2DP-27-T-0079

DLA procurement of 60 bottles of moxifloxacin hydrochloride tablets

**Posted:** October 09, 2026
**Respond By:** October 14, 2026
**Identifier:** SPE2DP-27-T-0079
**NAICS:** 424210, 325412

DLA Troop Support is seeking moxifloxacin hydrochloride tablets for military medical supply needs.
- **Government buyer:** Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA; contracting contact: Nicholas Quigley.
- **Product and quantity:** 60 bottles total of moxifloxacin hydrochloride 400 mg tablets, 30 tablets per bottle; NSN 6505-01-503-4772. The seven order quantities are 5, 10, 1, 5, 12, 12, and 15 bottles.
- **Named OEMs / approved sources:** **Teva Pharmaceuticals USA, Inc.** (NDC 00093-7387-56) and **Rising Pharma Holdings, Inc.** (NDC 57237-0156-30).
- **Delivery and handling:** Delivery is required within 5 days after order for multiple Navy vessels and a Fort Hood unit. The FDA-regulated product must be stored at controlled room temperature, protected from high humidity, and supplied with a 36-month, non-extendable shelf life.

### Description

MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7017192160)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 10, NSN: 6505-01-503-4772, Purchase Request: 7017651238)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7017383383)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7016833667)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7016895121)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7017319340)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 15, NSN: 6505-01-503-4772, Purchase Request: 7017190258)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP27T0079)